Malaria Therapy

New hope for malaria control in African infants

Published in Medical Letter on the CDC and FDA, August 15th, 2004

The Intermittent Preventive Treatment in Infants (IPTi) Consortium announced that it has received grants totaling US$16 million from the Bill & Melinda Gates Foundation to evaluate a promising intervention for malaria control in infants.

The Consortium will conduct five studies of IPTi in Africa, to be coordinated by the newly established Secretariat in Barcelona. The grants are part of a US$28 million commitment to support the Consortium announced by the Gates Foundation in September 2003.

IPTi is a potential way of using existing antimalarial drugs to protect infants from the worst effects of the disease. Under this approach, infants receive an...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2004-08-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry